ClearPoint Neuro (CLPT) Operating Leases (2019 - 2026)

ClearPoint Neuro (CLPT) has 8 years of Operating Leases data on file, last reported at $13.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 379.37% year-over-year to $13.7 million; the trailing twelve-month figure through Mar 2026 stood at $13.7 million (up 379.37% YoY), and the FY2025 full-year result was $8.5 million, up 181.0% from the prior year.
• Operating Leases climbed to $13.7 million in Q1 2026, from $8.5 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $13.7 million in Q1 2026 to a low of $1.4 million in Q1 2023.
• A 5-year average of $4.1 million and a median of $3.3 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases retreated 25.88% in 2022 and surged 379.37% in 2026, its largest moves.
• Tracing CLPT's Operating Leases over 5 years: stood at $1.5 million in 2022, then jumped by 132.9% to $3.6 million in 2023, then retreated by 15.61% to $3.0 million in 2024, then jumped by 181.0% to $8.5 million in 2025, then jumped by 62.04% to $13.7 million in 2026.
• Business Quant data shows CLPT's Operating Leases at $13.7 million in Q1 2026, $8.5 million in Q4 2025, and $6.2 million in Q3 2025.